Literature DB >> 34932591

Effect of breastfeeding for 6 months on disease outcomes in patients with Kawasaki disease.

Mindy Ming-Huey Guo1,2, I-Hsin Tsai3, Ho-Chang Kuo1,2.   

Abstract

BACKGROUND: Kawasaki disease (KD) is a systematic vasculitis that occurs predominantly in young children, and is the leading cause of acquired heart disease in children younger than five-years-old in developed countries. Although the etiology of KD is unknown, it is believed to be an inflammatory disease resulting from abnormal immune responses to possible environmental or infectious stimuli in genetically predisposed individuals. Breast milk contains numerous anti-inflammatory factors which may protect against allergic and autoimmune diseases. In this study we tried to examine the effect of breastfeeding for 6 months or more on disease outcomes in patients with Kawasaki disease.
METHODS: A retrospective cohort study of 249 KD patients admitted from 1999- 2013 who were older than 6 months at time of diagnosis and had data regarding breastfeeding in the first 6 months of life. Demographic, clinical and laboratory data was collected by chart review. Continuous data was compared using Student's t-test and categorical variables were compared using Chi-square. Stepwise multivariate regression of all demographic factors was performed.
RESULTS: Breastfeeding for 6 months or more was associated with a shorter total duration of fever (5.980± 1.405 Vs. 6.910 ± 2.573 days, p = 0.001) and a lower risk of developing persistent coronary artery lesions (CALs) (7.8% Vs. 20.2%, p-value = 0.039) on univariate analysis. Multivariate regression of all factors associated with CALs including breastfeeding for 6 months found that only the presence of CALs at baseline (β-coefficient = 0.065, p < 0.001) and white blood count (β-coefficient = 0.065, p = 0.018) remained significant after regression analysis.
CONCLUSIONS: Breastfeeding for 6 months or more was associated with a shorter duration of fever and a lower risk of persistent CAL formation in patients with KD on univariate analysis, although this effect may be modest when other factors such as the presence of CALs at baseline and white blood cell count are also taken into consideration.

Entities:  

Mesh:

Year:  2021        PMID: 34932591      PMCID: PMC8691627          DOI: 10.1371/journal.pone.0261156

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  30 in total

1.  Infections and Kawasaki disease: implications for coronary artery outcome.

Authors:  Susanne M Benseler; Brian W McCrindle; Earl D Silverman; Pascal N Tyrrell; Joseph Wong; Rae S M Yeung
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

2.  Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.

Authors:  M M-H Guo; W-N Tseng; C-H Ko; H-M Pan; K-S Hsieh; H-C Kuo
Journal:  Allergy       Date:  2015-01-14       Impact factor: 13.146

3.  Follow-up study of coronary artery lesions due to Kawasaki disease by serial selective coronary arteriography in 200 patients.

Authors:  A Suzuki; T Kamiya; Y Ono; T Kohata; K Kimura; M Takamiya
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

4.  Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience.

Authors:  Kenji Suda; Motofumi Iemura; Hiroshi Nishiono; Yozo Teramachi; Yusuke Koteda; Shintaro Kishimoto; Yoshiyuki Kudo; Shinichi Itoh; Haruka Ishii; Takafumi Ueno; Tadashi Tashiro; Masakiyo Nobuyoshi; Hirohisa Kato; Toyojiro Matsuishi
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

6.  Interleukin-10 in human milk.

Authors:  R Garofalo; S Chheda; F Mei; K H Palkowetz; H E Rudloff; F C Schmalstieg; D K Rassin; A S Goldman
Journal:  Pediatr Res       Date:  1995-04       Impact factor: 3.756

7.  Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease.

Authors:  Chi-Chieh Lai; Pi-Chang Lee; Chih-Chien Wang; Be-Tau Hwang; C C Laura Meng; Ming-Chih Tsai
Journal:  Pediatr Neonatol       Date:  2012-12-03       Impact factor: 2.083

8.  Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.

Authors:  Ho-Chang Kuo; Chih-Lu Wang; Chi-Di Liang; Hong-Ren Yu; Chien-Fu Huang; Lin Wang; Kao-Pin Hwang; Kuender D Yang
Journal:  Pediatr Allergy Immunol       Date:  2009-05       Impact factor: 6.377

9.  Association between breastfeeding and Kawasaki disease: a case-control study.

Authors:  Shun Wang; Dan Xiang; Congcong Fang; Baozhen Yao
Journal:  Eur J Pediatr       Date:  2019-12-03       Impact factor: 3.183

10.  Early feeding and risk of Juvenile idiopathic arthritis: a case control study in a prospective birth cohort.

Authors:  Erik Kindgren; Mats Fredrikson; Johnny Ludvigsson
Journal:  Pediatr Rheumatol Online J       Date:  2017-05-26       Impact factor: 3.054

View more
  2 in total

1.  Breastfeeding has no protective effects on the development of coronary artery lesions in Kawasaki disease: a retrospective cohort study.

Authors:  Hongli Wang; Yunjia Tang; Wenhua Yan; Qiuqin Xu; Xuan Li; Weiguo Qian
Journal:  BMC Pediatr       Date:  2022-06-20       Impact factor: 2.567

2.  Can Breastfeeding Protect from Multi-System Inflammatory Syndrome in Children (MIS-C)? A Preliminary Study.

Authors:  Xavier Rodríguez-Fanjul; Sergio Verd; Sonia Brio
Journal:  Children (Basel)       Date:  2022-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.